Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis

Hyperglycemia is associated with increased mortality and morbidity in patients with type 2 diabetes mellitus (T2DM) who are undergoing dialysis. Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been widely used in end-stage renal disease (ESRD) patients with T2DM, there are few studies on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Se Hee, Nam, Joo Young, Han, Eugene, Lee, Yong-ho, Lee, Byung-Wan, Kim, Beom Seok, Cha, Bong-Soo, Kim, Chul Sik, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985332/
https://www.ncbi.nlm.nih.gov/pubmed/27512877
http://dx.doi.org/10.1097/MD.0000000000004543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985332/
https://www.ncbi.nlm.nih.gov/pubmed/27512877
http://dx.doi.org/10.1097/MD.0000000000004543

Ejemplares similares